Hyperglycemia  >>  Adlyxin (lixisenatide)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

9 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Adlyxin (lixisenatide) / Sanofi
GETGOAL-MONO, NCT00688701 / 2007-005887-29: GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy

Checkmark P3 data
Mar 2012 - Mar 2012: P3 data
Completed
3
361
Japan, US, Europe, RoW
Lixisenatide (AVE0010), Placebo, Pen auto-injector, OptiClik®
Sanofi
Diabetes Mellitus, Type 2
12/09
12/09
GETGOAL-L-ASIA, NCT00866658: GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin +/- Sulfonylurea

Checkmark EASD 2013
Jul 2013 - Jul 2013: EASD 2013
Checkmark ADA 2013
Jun 2013 - Jun 2013: ADA 2013
Checkmark Data
More
Completed
3
311
Japan, RoW
Lixisenatide (AVE0010), Placebo, Pen auto-injector, OptiClik®, Sulfonylurea, Basal Insulin
Sanofi
Diabetes Mellitus, Type 2
06/10
06/10
GETGOAL-X, NCT00707031 / 2007-005883-28: GLP-1 Receptor Agonist Lixisenatide Versus Exenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin

Checkmark
May 2013 - May 2013: 
Checkmark Data
Jul 2011 - Jul 2011: Data
Checkmark Data
More
Completed
3
639
US, Europe, RoW
Lixisenatide (AVE0010), Pen auto-injector, OptiClik®, Exenatide, Byetta®, Prefilled pen injector, Metformin
Sanofi
Diabetes Mellitus, Type 2
11/10
11/10
GETGOAL-S, NCT00713830 / 2007-005881-11: GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Sulfonylurea

Checkmark
Mar 2014 - Mar 2014: 
Checkmark EASD 2013
Jul 2013 - Jul 2013: EASD 2013
Checkmark ADA 2013
More
Completed
3
859
Japan, US, Europe, RoW
Lixisenatide (AVE0010), Placebo, Pen auto-injector, OptiClik®, Sulfonylurea, Metformin
Sanofi
Diabetes Mellitus, Type 2
01/11
01/11
GETGOAL-F1, NCT00763451 / 2008-001002-16: GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin

Checkmark
Oct 2013 - Oct 2013: 
Checkmark Data
Nov 2011 - Nov 2011: Data
Checkmark Data
More
Completed
3
484
US, Europe, RoW
Lixisenatide (AVE0010), Placebo, Pen auto-injector, OptiClik®, Metformin
Sanofi
Diabetes Mellitus, Type 2
01/11
01/11
GETGOAL-MONO, NCT00905255: GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy ( Japan LTS)

Completed
3
69
Japan
Lixisenatide (AVE0010), Pen auto-injector, OptiClik®
Sanofi
Diabetes Mellitus, Type 2
01/11
01/11
GETGOAL-L, NCT00715624 / 2007-005886-36: GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin

Checkmark EASD 2013
Jul 2013 - Jul 2013: EASD 2013
Checkmark EASD 2013
Jul 2013 - Jul 2013: EASD 2013
Checkmark
More
Completed
3
496
US, Canada, Europe, RoW
Lixisenatide (AVE0010), Placebo, Basal Insulin, Metformin, Pen auto-injector, OptiClik®
Sanofi
Diabetes Mellitus, Type 2
02/11
02/11
GETGOAL-M, NCT00712673 / 2007-005880-80: GLP-1 Receptor Agonist Lixisenatide (Morning or Evening) in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin

Checkmark EASD 2013
Jul 2013 - Jul 2013: EASD 2013
Checkmark
Mar 2013 - Mar 2013: 
Checkmark Data
More
Completed
3
680
US, Canada, Europe, RoW
Lixisenatide (AVE0010), Placebo, Pen auto-injector, OptiClik®, Metformin
Sanofi
Diabetes Mellitus, Type 2
03/11
03/11
GETGOAL-P, NCT00763815 / 2007-005884-92: GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Pioglitazone

Checkmark
May 2013 - May 2013: 
Checkmark P3 data - ADA
May 2012 - May 2012: P3 data - ADA
Completed
3
484
US, Canada, Europe, RoW
Lixisenatide (AVE0010), Placebo, Pen auto-injector, OptiClik®, Pioglitazone, Metformin
Sanofi
Diabetes Mellitus Type 2
06/11
06/11

Download Options